Cite
HARVARD Citation
Loupakis, F. et al. (2019). Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status. Journal for immunotherapy of cancer. 7 (1), p. . [Online].